AAAAAA

   
Results: 1-7 |
Results: 7
IMPACT OF RENAL DYSFUNCTION ON METABOLITES OF NITRIC-OXIDE (NO) IN RENAL-ALLOGRAFT RECIPIENTS
Authors: DAI FX WINKLHOFER F COWLEY B CHONKO A PIERCE G GREATHOUSE J LAYES D SKOPEC J DIEDERICH A DIEDERICH D
Citation: Fx. Dai et al., IMPACT OF RENAL DYSFUNCTION ON METABOLITES OF NITRIC-OXIDE (NO) IN RENAL-ALLOGRAFT RECIPIENTS, Journal of the American Society of Nephrology, 8, 1997, pp. 3053-3053
MYCOPHENOLATE SUPPRESSES NITRIC-OXIDE (NO) PRODUCTION DURING ANTILYMPHOCYTE THERAPY IN RENAL-ALLOGRAFT RECIPIENTS
Authors: WINKLHOFER F DAI FX COWLEY B CHONKO A PIERCE G GREATHOUSE J LAYES D SKOPEC J DIEDERICH A DIEDERICH D
Citation: F. Winklhofer et al., MYCOPHENOLATE SUPPRESSES NITRIC-OXIDE (NO) PRODUCTION DURING ANTILYMPHOCYTE THERAPY IN RENAL-ALLOGRAFT RECIPIENTS, Journal of the American Society of Nephrology, 8, 1997, pp. 3287-3287
MARKERS OF MASKED IRON-DEFICIENCY AND EFFECTIVENESS OF EPO THERAPY INCHRONIC-RENAL-FAILURE
Authors: AHLUWALIA N SKIKNE BS SAVIN V CHONKO A
Citation: N. Ahluwalia et al., MARKERS OF MASKED IRON-DEFICIENCY AND EFFECTIVENESS OF EPO THERAPY INCHRONIC-RENAL-FAILURE, American journal of kidney diseases, 30(4), 1997, pp. 532-541
LOW-DOSE FELODIPINE DOES NOT INCREASE ALBUMIN EXCRETION - RESULTS OF A 6 MONTHS PROSPECTIVE-STUDY IN NORMOTENSIVE PATIENTS WITH TYPE-I DIABETES-MELLITUS
Authors: SOLCHER S DONALDSON D MACDOUGALL M MOORE W CHONKO A WIEGMANN T
Citation: S. Solcher et al., LOW-DOSE FELODIPINE DOES NOT INCREASE ALBUMIN EXCRETION - RESULTS OF A 6 MONTHS PROSPECTIVE-STUDY IN NORMOTENSIVE PATIENTS WITH TYPE-I DIABETES-MELLITUS, Journal of the American Society of Nephrology, 7(9), 1996, pp. 599-599
IRON-ABSORPTION AFTER STIMULATION OF ERYTHROPOIESIS WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN (RHUEPO) IN CHRONIC-RENAL-FAILURE
Authors: SKIKNE BS AHLUWALIA N SAVIN V CHONKO A COOK JD
Citation: Bs. Skikne et al., IRON-ABSORPTION AFTER STIMULATION OF ERYTHROPOIESIS WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN (RHUEPO) IN CHRONIC-RENAL-FAILURE, The FASEB journal, 9(4), 1995, pp. 982-982
RAMIPRIL (R) HAS AN ANTIPROTEINURIC EFFECT AND MAINTAINS RENAL-FUNCTION IN PATIENTS WITH TYPE-I DIABETES-MELLITUS (DM) - A PROSPECTIVE DOUBLE-BLIND DOSE-FINDING TRIAL (PRT)
Authors: CHONKO A DONALDSON D MOORE W MACDOUGALL M WIEGMANN T
Citation: A. Chonko et al., RAMIPRIL (R) HAS AN ANTIPROTEINURIC EFFECT AND MAINTAINS RENAL-FUNCTION IN PATIENTS WITH TYPE-I DIABETES-MELLITUS (DM) - A PROSPECTIVE DOUBLE-BLIND DOSE-FINDING TRIAL (PRT), Clinical research, 41(3), 1993, pp. 10000656-10000656
SERUM TRANSFERRIN RECEPTOR (TFR) AND AUTOMATED RETICULOCYTE COUNTS ARE EARLY MARKERS OF MARROW RESPONSE TO RECOMBINANT-HUMAN-ERYTHROPOIETIN(RHUEPO)
Authors: SKIKNE BS AHLUWALIA N SAVIN V CHONKO A COOK JD
Citation: Bs. Skikne et al., SERUM TRANSFERRIN RECEPTOR (TFR) AND AUTOMATED RETICULOCYTE COUNTS ARE EARLY MARKERS OF MARROW RESPONSE TO RECOMBINANT-HUMAN-ERYTHROPOIETIN(RHUEPO), Blood, 82(10), 1993, pp. 10000093-10000093
Risultati: 1-7 |